| Douglas John Austin, MD | |
|
590 Country Club Pkwy, Ste. A, Eugene, OR 97401-6025 | |
| (541) 485-2777 | |
| (541) 246-2353 |
| Full Name | Douglas John Austin |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 590 Country Club Pkwy, Eugene, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891738332 | NPI | - | NPPES |
| 150190 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | MD20456 (Oregon) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womens Care Pc | 8820986458 | 32 |
News Archive
Today the nonprofit Alliance for Aging Research released a white paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides a comprehensive overview of the factors that drive vaccination underutilization in seniors and offers recommendations on how industry, government, and health care experts can improve patient compliance.
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled trips to the doctor, missed less days from school or childcare, and caused their parents to take fewer days off work for their care.
GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that during their first week of real world evaluation trials, for their fully autonomous personal companion home care robot, the CareBot™, they have learned some surprising and some, not surprising, insights.
Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
› Verified 4 days ago
| Entity Name | Womens Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144250044 PECOS PAC ID: 8820986458 Enrollment ID: O20040305001026 |
News Archive
Today the nonprofit Alliance for Aging Research released a white paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides a comprehensive overview of the factors that drive vaccination underutilization in seniors and offers recommendations on how industry, government, and health care experts can improve patient compliance.
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled trips to the doctor, missed less days from school or childcare, and caused their parents to take fewer days off work for their care.
GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that during their first week of real world evaluation trials, for their fully autonomous personal companion home care robot, the CareBot™, they have learned some surprising and some, not surprising, insights.
Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas John Austin, MD Po Box 70368, Springfield, OR 97475-0120 Ph: (541) 485-2777 | Douglas John Austin, MD 590 Country Club Pkwy, Ste. A, Eugene, OR 97401-6025 Ph: (541) 485-2777 |
News Archive
Today the nonprofit Alliance for Aging Research released a white paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides a comprehensive overview of the factors that drive vaccination underutilization in seniors and offers recommendations on how industry, government, and health care experts can improve patient compliance.
Shire plc, the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R).
Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled trips to the doctor, missed less days from school or childcare, and caused their parents to take fewer days off work for their care.
GeckoSystems Intl. Corp. (http://www.geckosystems.com/) announced today that during their first week of real world evaluation trials, for their fully autonomous personal companion home care robot, the CareBot™, they have learned some surprising and some, not surprising, insights.
Oculus Innovative Sciences, Inc., a commercial medical technology company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, today announced that it has received new 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new dermatology indications for Microcyn® Skin and Wound HydroGel.
› Verified 4 days ago
John York, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 590 Country Club Pkwy, Suite B, Eugene, OR 97401 Phone: 541-686-2922 Fax: 541-683-1709 | |
Katria Laurel Mertz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way, Suite 220, Eugene, OR 97401 Phone: 541-686-7007 Fax: 541-726-5028 | |
Dr. Audrey Paige Garrett, M.D. , MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 520 Country Club Pkwy, Eugene, OR 97401 Phone: 541-683-5001 Fax: 541-683-1422 | |
Tamara A Stenshoel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 10 Coburg Rd, Ste 100, Eugene, OR 97401 Phone: 541-342-8616 Fax: 541-686-4814 | |
Dr. Brant L. Cooper, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Country Club Pkwy, Ste. B, Eugene, OR 97401 Phone: 541-485-2777 Fax: 541-246-2353 | |
Dr. Martha M Reilly, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 S Garden Way, Suite 220, Eugene, OR 97401 Phone: 541-686-7007 Fax: 541-726-5028 | |
Heather Lynne York, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 590 Country Club Pkwy, Ste B, Eugene, OR 97401 Phone: 541-485-2777 Fax: 541-246-2353 |